Adinolfi E,
Raffaghello L, Giuliani AL, Cavazzini L, Capece M, Chiozzi P,
Bianchi G, Kroemer G, Pistoia V, Di Virgilio F. Expression of
the P2X7 receptor increases in vivo tumor growth.
Cancer Res. 2012 Apr
13.
Bangert A, Cristofanon S, Eckhardt I, Abhari BA, Kolodziej S, Häcker S, Vellanki SH, Lausen J, Debatin KM, Fulda S. Histone deacetylase inhibitors sensitize glioblastoma cells to TRAIL-induced apoptosis by c-myc-mediated downregulation of cFLIP. Oncogene. 2012 Jan 23. doi: 10.1038/onc.2011.614.
Bennetzen MV, Mariño G, Pultz D, Morselli E, Færgeman NJ,
Kroemer G, Andersen JS.
Phosphoproteomic analysis of cells treated with
longevity-related autophagy inducers.
Cell Cycle. 2012 May 1;11(9).
Bennetzen MV, Cox J, Mann M,
Andersen JS.
PhosphoSiteAnalyzer: A
bioinformatic platform for deciphering phospho proteomes using
kinase predictions retrieved from NetworKIN.
J Proteome Res. 2012 Apr 3.
Carafa V, Nebbioso A,
Altucci L.
Sirtuins and disease: the road ahead.
Front Pharmacol. 2012;3:4.
Criollo A, Chereau F,
Malik SA, Niso-Santano M, Mariño G, Galluzzi L, Maiuri MC, Baud
V, Kroemer G. Autophagy is required for the activation of NFκB.
Cell Cycle. 2012 Jan 1;11(1).
Dell'aversana C, Lepore I, Altucci L.HDAC modulation and cell death in the clinic. Exp Cell Res. 2012 Feb 3.
D'Eletto M, Farrace
MG, Rossin F, Strappazzon F, Giacomo GD, Cecconi F, Melino G,
Sepe S, Moreno S, Fimia GM, Falasca L, Nardacci R,
Piacentini M.
Type 2 transglutaminase is involved in the autophagy-dependent
clearance of ubiquitinated proteins.
Cell Death Differ. 2012 Feb 10. doi:
10.1038/cdd.2012.2.
Fulda
S. Cell death pathways as
therapeutic targets in rhabdomyosarcoma.
Sarcoma. 2012;2012:326210.
Fulda
S, Vucic D. Targeting IAP proteins for therapeutic intervention
in cancer. Nat Rev Drug Discov.
2012 Feb 1;11(2):109-24. doi: 10.1038/nrd3627. Review.
Fulda S. Histone
deacetylase (HDAC) inhibitors and regulation of TRAIL-induced
apoptosis. Exp Cell Res.
2012 Feb 15.
Fulda S.
Regulation of apoptosis pathways in cancer stem cells.
Cancer Lett. 2012 Mar 16.
Fulda S. Exploiting
Inhibitor of Apoptosis (IAP) proteins as therapeutic targets in
hematological malignancies. Leukemia.
2012 Jan 9. doi: 10.1038/leu.2012.4.
Galluzzi L, Vitale I, Abrams JM, Alnemri ES, Baehrecke EH, Blagosklonny MV, Dawson TM, Dawson VL, El-Deiry WS, Fulda S, Gottlieb E, Green DR, Hengartner MO, Kepp O, Knight RA, Kumar S, Lipton SA, Lu X, Madeo F, Malorni W, Mehlen P, Nuñez G, Peter ME, Piacentini M, Rubinsztein DC, Shi Y, Simon HU, Vandenabeele P, White E, Yuan J, Zhivotovsky B, Melino G, Kroemer G. Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ. 2012. Jan;19(1):107-20.
Galluzzi L, Morselli
E, Kepp O, Vitale I, Younes AB, Maiuri MC, Kroemer G. Evaluation
of rapamycin-induced cell death.
Methods Mol Biol. 2012;821:125-69.
Galluzzi L, Senovilla
L, Zitvogel L, Kroemer
G. The secret ally: immunostimulation by anticancer
drugs. Nat Rev Drug Discov.
2012 Feb 3;11(3):215-33.
Galluzzi L, Kepp O,
Trojel-Hansen C, Kroemer
G. Non-apoptotic functions of apoptosis-regulatory
proteins. EMBO Rep.
2012 Mar 9. doi: 10.1038/embor.2012.19.
Gonzalez P, Mader I,
Tchoghandjian A, Enzenmüller S, Cristofanon S, Basit F, Debatin
KM, Fulda S. Impairment of lysosomal integrity by B10, a
glycosylated derivative of betulinic acid, leads to lysosomal
cell death and converts autophagy into a detrimental process.
Cell Death Differ. 2012 Feb 17. doi:
10.1038/cdd.2012.10.
Koh GC, Porras P, Aranda B, Hermjakob H, Orchard SE.Analyzing Protein-Protein Interaction Networks (†).J Proteome Res. 2012 Mar 2.
Garg AD, Krysko DV,
Verfaillie T, Kaczmarek A, Ferreira GB, Marysael T, Rubio N,
Firczuk M, Mathieu C, Roebroek AJ, Annaert W, Golab J, de Witte
P, Vandenabeele P, Agostinis P. A novel pathway combining
calreticulin exposure and ATP secretion in immunogenic cancer
cell death. EMBO J.
2012 Jan 17. doi: 10.1038/emboj.2011.497.
Hannani D, Ma Y,
Yamazaki T, Déchanet-Merville J, Kroemer G, Zitvogel L.
Harnessing γδ T cells in anticancer immunotherapy.
Trends Immunol. 2012 Feb 22
Huber HJ, Connolly NM, Dussmann H, Prehn JH.
A structured approach to the study of
metabolic control principles in intact and impaired
mitochondria. Mol Biosyst.
2012 Jan 5.
Huhn S, Pardini B,
Naccarati A, Vodicka P, Hemminki K, Försti A. Ancestral
susceptibility to colorectal cancer.
Mutagenesis. 2012 Mar;27(2):197-204.
Jäger R, Bertrand MJ,
Gorman AM, Vandenabeele P, Samali A. The unfolded protein
response at the crossroads of cellular life and death during ER
stress. Biol Cell.
2012 Jan 23. doi: 10.1111/boc.201100055.
Kaminskyy V, Zhivotovsky B. Proteases in autophagy. Biochim Biophys Acta. 2012, Jan;1824(1):44-50 .
Karlebach G, Shamir R. Constructing Logical Models of Gene Regulatory Networks by Integrating Transcription Factor-DNA Interactions with Expression Data: An Entropy-Based Approach. J Comput Biol. 2012 Jan;19(1):30-41
Kerrien S, Aranda B,
Breuza L, Bridge A, Broackes-Carter F, Chen C, Duesbury M,
Dumousseau M, Feuermann M, Hinz U, Jandrasits C, Jimenez RC,
Khadake J, Mahadevan U, Masson P, Pedruzzi I, Pfeiffenberger E,
Porras P, Raghunath A, Roechert B, Orchard S,
Hermjakob H. The
IntAct molecular interaction database in 2012.
Nucleic Acids Res. 2012
Jan;40(1):D841-6.
Kruspig B, Nilchian A, Bejarano I, Orrenius S, Zhivotovsky B, Gogvadze V. Targeting mitochondria by α-tocopheryl succinate kills neuroblastoma cells irrespective of MycN oncogene expression. Cell Mol Life Sci. 2012 Jan 28.
Martins I, Michaud M,
Sukkurwala AQ, Adjemian S, Ma Y, Shen S, Kepp O, Menger L,
Vacchelli E, Galluzzi L, Zitvogel L, Kroemer G. Premortem
autophagy determines the immunogenicity of chemotherapy-induced
cancer cell death. Autophagy.
2012 Mar 1;8(3).
Niso-Santano M,
Criollo A, Malik SA, Michaud M, Mariño G, Lachkar S, Galluzzi L,
Kroemer G. Direct
molecular interactions between Beclin 1 and the canonical NFκB
activation pathway. Autophagy.
2012 Feb 1;8(2):268-70
Pagliarini V, Wirawan
E, Romagnoli A, Ciccosanti F, Lisi G, Lippens S, Cecconi F,
Fimia GM, Vandenabeele P, Corazzari M,
Piacentini M.
Proteolysis of Ambra1 during apoptosis has a role in the
inhibition of the autophagic pro-survival response.
Cell Death Differ. 2012 Mar 23. doi:
10.1038/cdd.2012.27.
Pultz D, Bennetzen MV, Rødkær SV, Zimmermann C, Enserink JM,
Andersen JS, Færgeman NJ. Global
mapping of protein phosphorylation events identifies Ste20, Sch9
and the cell-cycle regulatory kinases Cdc28/Pho85 as mediators
of fatty acid starvation responses in Saccharomyces cerevisiae.
Mol Biosyst. 2012 Jan 4.
Rafn B, Nielsen CF,
Andersen SH, Szyniarowski P, Corcelle-Termeau E, Valo E,
Fehrenbacher N, Olsen CJ, Daugaard M, Egebjerg C, Bøttzauw T,
Kohonen P, Nylandsted J, Hautaniemi S, Moreira J, Jäättelä M,
Kallunki T. ErbB2-Driven Breast Cancer Cell Invasion Depends on
a Complex Signaling Network Activating Myeloid Zinc
Finger-1-Dependent Cathepsin B Expression.
Mol Cell. 2012 Mar 30;45(6):764-76.
Ring J, Sommer C,
Carmona-Gutierrez D, Ruckenstuhl C, Eisenberg T,
Madeo F. The
metabolism beyond programmed cell death in yeast.
Exp Cell Res. 2012 Mar 27.
Rello-Varona S, Lissa
D, Shen S, Niso-Santano M, Senovilla L, Mariño G, Vitale I,
Jemaá M, Harper F, Pierron G, Castedo M,
Kroemer G.
Autophagic removal of micronuclei.
Cell Cycle. 2012 Jan 1;11(1).
Sabatino L, Fucci A,
Pancione M, Carafa V, Nebbioso A, Pistore C, Babbio F, Votino C,
Laudanna C, Ceccarelli M, Altucci L, Bonapace IM, Colantuoni V.
UHRF1 coordinates peroxisome proliferator activated receptor
gamma (PPARG) epigenetic silencing and mediates colorectal
cancer progression. Oncogene.
2012 Jan 30. doi: 10.1038/onc.2012.3.
Shen S, Kepp O, Kroemer G. The end of autophagic cell
death? Autophagy.
2012 Jan 1;8(1).
Surova O, Akbar NS,
Zhivotovsky B. Knock-Down of Core Proteins Regulating MicroRNA
Biogenesis Has No Effect on Sensitivity of Lung Cancer Cells to
Ionizing Radiation. PLoS One.
2012;7(3):e33134.
Zinovyev A, Fourquet
S, Tournier L, Calzone L,
Barillot E. Cell
death and life in cancer: mathematical modeling of cell fate
decisions. Adv Exp Med Biol.
2012;736:261-74.
Zitvogel L, Kepp O,
Galluzzi L, Kroemer G.
Inflammasomes in carcinogenesis and anticancer immune responses.
Nat Immunol.
2012 Mar 18;13(4):343-51. doi: 10.1038/ni.2224.
Vanlangenakker N,
Vanden Berghe T,
Vandenabeele P. Many stimuli pull the necrotic trigger,
an overview. Cell Death Differ.
2012 Jan;19(1):75-86.
Wagner L, Marschall
V, Karl S, Cristofanon S, Zobel K, Deshayes K, Vucic D, Debatin
KM, Fulda S. Smac mimetic sensitizes glioblastoma cells to Temozolomide-induced
apoptosis in a RIP1- and NF-κB-dependent manner.
Oncogene. 2012 Apr 2. doi:
10.1038/onc.2012.108
Wirawan E, Lippens S,
Vanden Berghe T, Romagnoli A, Fimia GM, Piacentini M,
Vandenabeele P. Beclin1: A role in membrane dynamics and beyond.
Autophagy. 2012 Jan 1;8(1).